RNS Number : 4779W
abrdn Private Equity Opp Trst plc
18 April 2023
 

abrdn Private Equity Opportunities Trust plc

Legal Entity Identifier (LEI): 2138004MK7VPTZ99EV13

 

18 April 2023

abrdn Private Equity Opportunities Trust plc ("APEO" or "the Company") announces its estimated net asset value ("NAV") at 31 March 2023

·      Estimated NAV at 31 March 2023 was 745.9 pence per share (estimated NAV at 28 February 2023 was 745.9 pence per share)

·      Excluding new investments, 97.4% by value of portfolio was dated 31 December 2022 (estimated NAV at 28 February 2023 was 76.3% dated 31 December 2022)

·      APEO paid £22.2 million of drawdowns and received £12.1 million of distributions during the month of March

·      Commitments to one co-investment follow-on and one new co-investment were made during the month of March

·      Outstanding commitments of £682.9 million at 31 March 2023

·      Liquid resources (cash balances plus undrawn credit facilities) were £227.1 million as at 31 March 2023

 

APEO's valuation policy for private equity funds and co-investments is based on the latest valuations reported by the managers of the funds and co-investments in which the Company has interests. In the case of APEO's valuation at 31 March 2023, excluding new investments, 97.4% by value of the portfolio valuations were dated 31 December 2022. The value of the portfolio is therefore generally calculated as the 31 December 2022 valuation, adjusted for subsequent cashflows over the period to 31 March 2023.

This is an update from the estimated NAV at 28 February 2023, whereby 76.3% of the portfolio valuations, excluding new investments, were dated 31 December 2022, adjusted for subsequent cashflows over the period to 28 February 2023.

 

Estimated NAV

At 31 March 2023, APEO's estimated NAV was 745.9 pence per share (estimated net assets £1,146.8 million), representing no overall movement from the estimated NAV at 28 February 2023 of 745.9 pence per share (estimated net assets £1,146.8 million). This nil movement in NAV per share during March was as a result of gains arising primarily from a 0.3% appreciation in the euro versus sterling and a 0.1% constant currency uplift in the valuation of investments as at 31 December 2022 received since the last announcement being offset by a 2.1% depreciation in the dollar versus sterling.

 

Drawdowns and distributions

APEO paid £22.2 million of drawdowns and received £12.1 million of distributions during the month of March. The distributions received generated realised gains and income of £4.0 million.

 

Investment activity

During March, the Company provided an additional commitment of €3.4 million to Funecap alongside Latour Capital as part of a shareholder reorganisation following a period of strong growth at the business. The additional capital will also be used to support future growth initiatives.

A €6.0 million commitment has also been made to a co-investment vehicle to fund the acquisition of an interest in an undisclosed business in the healthcare sector. This is alongside one of the Company's existing private equity managers. The details of the deal remain undisclosed due to confidentiality restrictions at this time.

 

Commitments

The Company had £682.9 million of outstanding commitments at 31 March 2023. The Manager believes that around £71.6 million of the Company's existing outstanding commitments are unlikely to be drawn.

 

Credit facility and cash balances

The Company has a £300.0 million syndicated revolving credit facility provided by The Royal Bank of Scotland International Limited, Societe Generale and State Street Bank International GmbH, and it expires in December 2025. The Company drew a total of £8.8 million from the facility during the month of March, increasing the total drawn balance to £92.8 million at 31 March 2023. The remaining undrawn balance of the facility at 31 March 2023 was therefore £207.2 million.

In addition, the Company had cash balances of £19.9 million at 31 March 2023. Liquid resources, calculated as the total of cash balances and the undrawn balance of the credit facility, were therefore £227.1 million as at 31 March 2023.

 

Update from the Manager

The latest update from the Manager is available within the Latest News section of the Company website; www.abrdnpeot.co.uk.

 

Future announcements

The Company is expecting to announce its estimated NAV at 30 April 2023 on or around 16 May 2023.

Additional detail about APEO's NAV and investment diversification can be found on APEO's website. Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website is incorporated into, or forms part of, this announcement.

 

For further information please contact Alan Gauld at abrdn Capital Partners LLP (0131 528 4424)

Notes:-

abrdn Private Equity Opportunities Trust plc is an investment company managed by abrdn Capital Partners LLP, the ordinary shares of which are admitted to listing by the UK Listing Authority and to trading on the Stock Exchange and which seeks to conduct its affairs so as to qualify as an investment trust under sections 1158-1165 of the Corporation Tax Act 2010. The Board of abrdn Private Equity Opportunities Trust plc is independent of abrdn plc and Phoenix Group Holdings.

The Company intends to release regular estimated NAV updates around ten business days after each month end. A breakdown of APEO's portfolio can be obtained in the latest monthly factsheet, which is published on APEO's website at:

www.abrdnpeot.co.uk


 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVBSGDSRSBDGXR